Purification and characterization of a novel antibacterial peptide against Clostridium perfringens
Microbiology · 2025
DOI: 10.1099/mic.0.001573 ↗Kurz gefasst
Fachartikel in der Zeitschrift Microbiology, 2025. Verfasst von Alex Novodvorski und 7 weiteren Autor:innen. Beteiligte Einrichtung: Guelph Research and Development Centre, Agriculture and Agri-Food Canada, Guelph, Ontario, N1G 5C9, Canada. Hauptthemen laut MEDLINE: Clostridium perfringens, Anti-Bacterial Agents, Antimicrobial Peptides, Bacillus. Die Arbeit nennt 33 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agriculture and Agri-Food Canada.
Abstract (Originalsprache)
Bacillus velezensis HG88 was isolated from ileal mucosa samples of egg layer hens that were raised without the use of antibiotics. Its cell-free supernatant (CFS) was found to inhibit the growth of Clostridium perfringens , the causative agent of necrotic enteritis in chickens. The inhibitory compound was determined to be proteinaceous due to its susceptibility to protease digestion. The antimicrobial activity was specific towards C. perfringens , as the CFS did not inhibit the growth of Gram-positive or Gram-negative bacteria across nine different species and two yeast fungi. Separation of proteins from the CFS followed by peptide mass fingerprinting and genomic analyses of the strain enabled the identification of a putative antibacterial peptide with an export signal for secretion from the cell. The peptide from B. velezensis HG88, named IP HG88 , has sequence similarity to bacterial SH3 domains that are known to bind to the peptide portion of peptidoglycan. The gene encoding this peptide was cloned, and the peptide was purified from recombinant Escherichia coli as an N-terminal His-tagged peptide. The IP HG88 with or without the His-tag inhibited the growth of C. perfringens with a minimum bactericidal concentration of ~57.0 or 39.1 µg ml −1 , respectively. The 3D structure of IP HG88 was also predicted using AlphaFold 2.0.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Guelph Research and Development Centre, Agriculture and Agri-Food Canada, Guelph, Ontario, N1G 5C9, Canada.
- Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, N1G 2W1, Canada.
- Food Research Division, Bureau of Chemical Safety, Health Canada, Ottawa, Ontario, K1A 0K9, Canada.
Förderung
- Agriculture and Agri-Food Canada
Zitieren
APA
Novodvorski, A., Kong, A., Yu, H., Lepp, D., Brott, A., Carere, J., Seah, S., & Gong, J. (2025). Purification and characterization of a novel antibacterial peptide against Clostridium perfringens. Microbiology. https://doi.org/10.1099/mic.0.001573
Vancouver
Novodvorski A, Kong A, Yu H, Lepp D, Brott A, Carere J, et al. Purification and characterization of a novel antibacterial peptide against Clostridium perfringens. Microbiology. 2025. doi:10.1099/mic.0.001573
BibTeX
@article{Novodvorski2025,
author = {Novodvorski, Alex and Kong, Avalene and Yu, Hai and Lepp, Dion and Brott, Ashley and Carere, Jason and Seah, Stephen and Gong, Joshua},
title = {Purification and characterization of a novel antibacterial peptide against Clostridium perfringens},
journal = {Microbiology},
year = {2025},
doi = {10.1099/mic.0.001573}
}
EUVIMED